Paul Davies

Title: Paul Davies - Innovator in Chemokine Receptor Technology

Introduction

Paul Davies is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of biochemistry, particularly in the development of chimeric chemokine receptors. His work has implications for various applications in medical research and drug development.

Latest Patents

Paul Davies holds a patent for "Polynucleotides encoding chimeric chemokine receptors." This invention relates to a chimeric chemokine receptor that comprises two components. The first sequence includes the N terminus through the last residue of the seven helix transmembrane region of a first chemokine receptor. This is joined with a second sequence that comprises the C terminus of a second chemokine receptor, extending from the first intracellular residue to the last residue of the chemokine receptor. The chimeric chemokine receptor can be employed in various applications, such as ligand binding and screening assays, as well as signaling assays. Additionally, it can form a component of a chemokine receptor modulator design program. Paul Davies has 1 patent to his name.

Career Highlights

Paul Davies is currently associated with Bristol-Myers Squibb Company, where he continues to innovate in the field of biochemistry. His work has been instrumental in advancing the understanding of chemokine receptors and their potential therapeutic applications.

Collaborations

Some of his notable coworkers include Joseph E. Dinchuk and Qihong Zhao. Their collaborative efforts have contributed to the success of various projects within the company.

Conclusion

Paul Davies is a distinguished inventor whose work on chimeric chemokine receptors has the potential to impact medical research significantly. His contributions to the field exemplify the importance of innovation in biochemistry.